Jean Bourbeau focuses on COPD, Physical therapy, Intensive care medicine, Exacerbation and Randomized controlled trial. His COPD research is classified as research in Internal medicine. Jean Bourbeau mostly deals with Pulmonary rehabilitation in his studies of Physical therapy.
Jean Bourbeau has included themes like Smoking cessation, Guideline, Obstructive lung disease, Spirometry and Comorbidity in his Intensive care medicine study. His Exacerbation research is multidisciplinary, relying on both Anesthesia, Prospective cohort study and Medical prescription. His Randomized controlled trial research incorporates elements of Pharmacotherapy and Emergency medicine.
Jean Bourbeau mainly focuses on COPD, Physical therapy, Internal medicine, Intensive care medicine and Pulmonary disease. Jean Bourbeau combines subjects such as Exacerbation, Randomized controlled trial and Spirometry with his study of COPD. His Exacerbation study integrates concerns from other disciplines, such as Medical prescription and Pediatrics.
His research investigates the link between Physical therapy and topics such as Placebo that cross with problems in Anesthesia. His Internal medicine study frequently draws connections to adjacent fields such as Cardiology. His Intensive care medicine study combines topics in areas such as Psychological intervention, Disease management, Disease and Quality of life.
His primary areas of study are COPD, Pulmonary disease, Internal medicine, Intensive care medicine and Obstructive lung disease. His COPD study combines topics from a wide range of disciplines, such as Exacerbation, Physical therapy, Quality of life and Asthma. His Physical therapy research incorporates themes from Olodaterol and Metabolic demand.
His studies deal with areas such as Blood eosinophils, Disease, Gerontology and Computed tomography as well as Pulmonary disease. His Internal medicine research includes elements of Gastroenterology and Cardiology. His Intensive care medicine study incorporates themes from Pharmacotherapy and Pharmacological therapy.
COPD, Pulmonary disease, Intensive care medicine, Internal medicine and Obstructive lung disease are his primary areas of study. His research in COPD intersects with topics in Psychological intervention, Exacerbation, Physical therapy and Pharmacotherapy. His work carried out in the field of Pulmonary disease brings together such families of science as Health equity, Disease progression, Evidence-based medicine and Gerontology.
His work deals with themes such as Precision medicine and Nicotine, which intersect with Intensive care medicine. His study explores the link between Internal medicine and topics such as Cardiology that cross with problems in Airflow obstruction, Nocturnal, Intention-to-treat analysis and Oxygen therapy. The various areas that Jean Bourbeau examines in his Obstructive lung disease study include Hazard ratio, Lung volumes, Rate ratio, Vaccination and Global health.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An official American thoracic society/European respiratory society statement: Key concepts and advances in pulmonary rehabilitation
Martijn A. Spruit;Sally J. Singh;Chris Garvey;Richard ZuWallack.
American Journal of Respiratory and Critical Care Medicine (2013)
American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation
Linda Nici;Claudio Donner;Emiel Wouters;Richard Zuwallack.
American Journal of Respiratory and Critical Care Medicine (2006)
An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea
Mark B Parshall;Richard M Schwartzstein;Lewis Adams;Robert B Banzett.
American Journal of Respiratory and Critical Care Medicine (2012)
Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease: A Disease-Specific Self-management Intervention
Jean Bourbeau;Marcel Julien;François Maltais;Michel Rouleau.
JAMA Internal Medicine (2003)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.
Dave Singh;Alvar Agusti;Antonio Anzueto;Peter J. Barnes.
European Respiratory Journal (2019)
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
Shawn D Aaron;Katherine L Vandemheen;Dean Fergusson;François Maltais.
Annals of Internal Medicine (2007)
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Claus F. Vogelmeier;Gerard J. Criner;Fernando J. Martinez;Antonio Anzueto.
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.
Denis E O’Donnell;Shawn Aaron;Jean Bourbeau;Paul Hernandez.
Canadian Respiratory Journal (2007)
Patient adherence in COPD
J Bourbeau;S J Bartlett.
A Comprehensive Care Management Program to Prevent Chronic Obstructive Pulmonary Disease Hospitalizations: A Randomized, Controlled Trial
Vincent S. Fan;J. Michael Gaziano;Robert Lew;Jean Bourbeau.
Annals of Internal Medicine (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: